logo
Nextdoor Reports First Quarter 2025 Results

Nextdoor Reports First Quarter 2025 Results

Business Wire07-05-2025

SAN FRANCISCO--(BUSINESS WIRE)--Nextdoor Holdings, Inc. (NYSE: KIND), the essential neighborhood network, today reported financial results for the first quarter ended March 31, 2025.
Nextdoor's highlighted metrics for the quarter ended March 31, 2025 include:
Total Weekly Active Users (WAU) of 46.1 million increased 6% year-over-year.
Revenue of $54 million increased 2% year-over-year.
Net loss was $22 million, compared to $28 million in the year-ago period.
Adjusted EBITDA loss was $9 million, compared to $14 million in the year-ago period.
Ending cash, cash equivalents, and marketable securities were $418 million as of March 31, 2025.
"In Q1 we continued to add new users, improved margins, and generated positive operating cash flow — though our most significant progress during Q1 was product-related," said Nextdoor CEO Nirav Tolia.
"By executing our transition to NEXT, we believe Nextdoor will emerge better positioned to be a daily use product with deeper engagement and improved monetization over time. I'm thrilled to report that our product development work remains on track, and we expect to deliver a completely new Nextdoor user experience by late July 2025."
For more detailed information on our operating and financial results for the first quarter ended March 31, 2025, as well as our outlook for Q2 and fiscal year 2025, please reference our Investor Update posted to our Investor Relations website located at investors.nextdoor.com.
Three Months Ended March 31,
(in thousands)
2025
2024
Net loss
$
(21,952
)
$
(28,261
)
Depreciation and amortization
544
1,387
Stock-based compensation
17,091
19,506
Interest income
(4,982
)
(6,846
)
Provision for income taxes
141
199
Adjusted EBITDA
$
(9,158
)
$
(14,015
)
Net loss % Margin
(41
)%
(53
)%
Adjusted EBITDA % Margin
(17
)%
(26
)%
Expand
Nextdoor will host a conference call at 2:00 p.m. PT/5:00 p.m. ET today to discuss these results and outlook. A live webcast of our first quarter 2025 earnings release call will be available in the Events & Presentations section of Nextdoor's Investor Relations website located at investors.nextdoor.com. After the live event, the audio recording for the webcast can be accessed on the same website for approximately one year.
Nextdoor uses its Investor Relations website (investors.nextdoor.com), its X handle (x.com/Nextdoor), its LinkedIn Home Page (linkedin.com/company/nextdoor-com), and Nirav Tolia's LinkedIn posts (www.linkedin.com/in/niravtolia /) and X posts (x.com/niravtolia) as a means of disseminating or providing notification of, among other things, news or announcements regarding its business or financial performance, investor events, press releases, and earnings releases, and as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD.
Non-GAAP Financial Measures
To supplement our condensed consolidated financial statements, which are prepared in accordance with GAAP, we present certain non-GAAP financial measures, such as adjusted EBITDA and adjusted EBITDA margin, in this press release. Our use of non-GAAP financial measures has limitations as an analytical tool, and these measures should not be considered in isolation or as a substitute for analysis of financial results as reported under GAAP.
We use non-GAAP financial measures in conjunction with financial measures prepared in accordance with GAAP for planning purposes, including in the preparation of our annual operating budget, as a measure of our core operating results and the effectiveness of our business strategy, and in evaluating our financial performance. Non-GAAP financial measures provide consistency and comparability with past financial performance, facilitate period-to-period comparisons of core operating results, and also facilitate comparisons with other peer companies, many of which use similar non-GAAP financial measures to supplement their GAAP results. In addition, adjusted EBITDA is widely used by investors and securities analysts to measure a company's operating performance. We exclude the following items from one or more of our non-GAAP financial measures: stock-based compensation expense (non-cash expense calculated by companies using a variety of valuation methodologies and subjective assumptions), depreciation and amortization (non-cash expense), interest income, provision for income taxes, and, if applicable, restructuring charges or acquisition-related costs.
Investors are cautioned that there are material limitations associated with the use of non-GAAP financial measures as an analytical tool. In particular, (1) stock-based compensation expense has recently been, and will continue to be for the foreseeable future, a significant recurring expense for our business and an important part of our compensation strategy, (2) although depreciation and amortization expense are non-cash charges, the assets subject to depreciation and amortization may have to be replaced in the future, and our non-GAAP measures do not reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements, and (3) adjusted EBITDA does not reflect: (a) changes in, or cash requirements for, our working capital needs; (b) interest expense, or the cash requirements necessary to service interest or principal payments on our debt, which reduces cash available to us; or (c) tax payments that may represent a reduction in cash available to us. The non-GAAP measures we use may be different from non-GAAP financial measures used by other companies, limiting their usefulness for comparison purposes. We compensate for these limitations by providing specific information regarding the GAAP items excluded from these non-GAAP financial measures.
About Nextdoor
Nextdoor (NYSE: KIND) is the essential neighborhood network. Neighbors, public agencies and businesses use Nextdoor to connect around local information that matters in more than 345,000 neighborhoods across 11 countries. Nextdoor builds innovative technology to foster local community, and brands and businesses of all sizes use Nextdoor's proprietary advertising platform to engage with neighborhoods at scale. Download the app or join the neighborhood at nextdoor.com. For more information and media assets, visit nextdoor.com/newsroom.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

1 Magnificent Growth Stock to Buy Before It Soars Higher After This Event
1 Magnificent Growth Stock to Buy Before It Soars Higher After This Event

Yahoo

time30 minutes ago

  • Yahoo

1 Magnificent Growth Stock to Buy Before It Soars Higher After This Event

Oracle stock gained momentum after its latest quarterly report. The stock seems primed for more upside thanks to rapidly growing demand for Oracle's cloud infrastructure. Oracle is on track to deliver faster earnings growth in the future, which could help the stock sustain its bull run. 10 stocks we like better than Oracle › Oracle (NYSE: ORCL) stock has been in fine form on the market over the past couple of months, gaining 77% from its April 21 52-week low. And it looks like this technology giant is primed for more upside following the release of its latest quarterly report. Oracle reported its fiscal 2025 fourth-quarter results (for the three months ended May 31) on June 11. The market reacted positively, pushing the price higher for reasons that aren't all that surprising. Oracle, which made its name by selling database management software, now benefits from the tremendous demand for its cloud infrastructure services. The company not only delivered better-than-expected numbers, but it also issued solid guidance that points toward an even better year. Let's take a look at Oracle's latest report and why it may be a good idea to buy the stock right away. Oracle ended fiscal 2025 with $57.4 billion in annual revenue, up 9% in constant currency terms. The company expects to deliver at least $67 billion in revenue in fiscal 2026 (a jump of almost 17%). Don't be surprised to see Oracle clock even stronger growth, as only some of the company's artificial intelligence (AI)-related catalysts are baked into the guidance. On the earnings call, Oracle Chief Technology Officer Larry Ellison said that the company's revenue pipeline could be much larger than what it is projected in the earnings report. The cloud giant reported a 41% year-over-year increase in its remaining performance obligations (RPO) in fiscal Q4 to $138 billion. RPO refers to the total value of Oracle's contracts that are yet to be fulfilled at the end of a quarter, and the massive increase in this metric explains why it is expecting a stronger top-line increase this year. CEO Safra Catz projects the company's RPO will more than double in fiscal 2026, outpacing the projected growth in its revenue, which can set the stage for years of strong growth for the company. This massive increase in Oracle's RPO can be attributed to the stunning demand for its cloud infrastructure, which is being used for AI training and inference purposes by customers. According to Ellison, Oracle could be understating its RPO if the $500 billion Stargate AI infrastructure project it is a part of pans out as expected. Oracle is one of the key technology partners and funders of the OpenAI-led venture that's backed by SoftBank and Abu Dhabi-based MGX, and it will "closely collaborate to build and operate" AI infrastructure as a part of this project. Meanwhile, the booming demand for cloud AI infrastructure to train and deploy AI applications in general is going to be a long-term tailwind for Oracle, which is finding it difficult to deploy enough capacity to meet the demand. Ellison told analysts on the earnings call that one of its customers wanted to buy Oracle's entire cloud capacity. Not surprisingly, Oracle is going to build 30 dedicated data centers in fiscal 2026, apart from the existing 29 that it already has. It also plans to increase its MultiCloud data centers, which it operates with other major cloud computing providers such as Amazon, Alphabet's Google, and Microsoft, from the current strength of 23 by building another 47 MultiCloud data centers over the next year. This focus on capacity expansion is the reason why the company is forecasting Oracle Cloud Infrastructure (OCI) revenue to grow at a faster pace of 70% in fiscal 2026, following a 50% jump last year. In all, Oracle could be at the beginning of a terrific growth curve, considering the potential catalysts such as Stargate and the opportunity in the cloud infrastructure-as-a-service (IaaS) market that's expected to generate a whopping $712 billion in revenue by 2032, growing at an annual rate of 21%. Oracle delivered non-GAAP (adjusted) net income of $6.03 per share in fiscal 2025, an increase of 8.5% from the prior year. Investors should note that the company's capital expenses more than tripled during the year to $21.2 billion. Its forecast of $25 billion in capital expenses for fiscal 2026, which points toward a slower increase from last year, explains why analysts expect faster bottom-line growth from Oracle this year, and beyond. Moreover, the company seems on its way to crushing its own long-term expectations. Oracle pointed out last year that it expects to hit $66 billion in revenue in fiscal 2026, but its forecast points toward a bigger jump. Also, Oracle expects its bottom line to grow at an annual pace of more than 20% through fiscal 2029. Oracle could eventually do better than that as the market it is serving is massive and the revenue pipeline it is building is remarkable. All this makes Oracle a top AI stock to buy right now as it is trading at just 31 times forward earnings. That's in line with the Nasdaq-100 index's earnings multiple, suggesting that investors can buy Oracle right now at a very attractive valuation, considering the healthy upside it could deliver in the long run. Before you buy stock in Oracle, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Oracle wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $659,171!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $891,722!* Now, it's worth noting Stock Advisor's total average return is 995% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Harsh Chauhan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet, Amazon, Microsoft, and Oracle. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy. 1 Magnificent Growth Stock to Buy Before It Soars Higher After This Event was originally published by The Motley Fool Sign in to access your portfolio

2 High-Yield Healthcare Dividend Stocks to Buy Hand Over Fist in June
2 High-Yield Healthcare Dividend Stocks to Buy Hand Over Fist in June

Yahoo

timean hour ago

  • Yahoo

2 High-Yield Healthcare Dividend Stocks to Buy Hand Over Fist in June

The average healthcare stock has a yield of just 1.7%. Medtronic's dividend yield is 3.3%. Alexandria Real Estate Equities' yield is 7.4%. 10 stocks we like better than Medtronic › The healthcare sector isn't exactly known for offering huge yields, with Health Care Select Sector SPDR (NYSEMKT: XLV) offering a yield of just 1.7%. If dividend investors take some time to dig into the sector, however, they can do much better. For example, Medtronic (NYSE: MDT) has a 3.3% yield today, and Alexandria Real Estate Equities (NYSE: ARE) is offering a yield of 7.4%. Here's what you need to know about each of these high-yield healthcare stocks. Medtronic makes medical devices. It is one of the largest competitors in the space, making products across the cardiovascular, neuroscience, medical surgical, and diabetes categories. It has a leading position in each of the areas in which it operates, and it operates on a global scale. That said, the last few years haven't been the best ones for the company. Innovation, which is highly important in the healthcare space, can be lumpy. And given Medtronic's size, the business has become a little cumbersome. Growth has stalled out, and profitability has come under pressure. Investors have focused on the negatives pushing the shares lower and the dividend yield up toward the high end of Medtronic's historical yield range. If you are a dividend investor that thinks in decades and not days, however, this is likely to be an investment opportunity. The company's innovation pipeline is starting to turn into new-product introductions. As new products gain traction, financial performance is likely to improve. And management has been working to streamline the business with cost cuts and a move to refocus on its most profitable operations. To that end, the company is set to spin off its lower-margin diabetes division in 2026. The move is expected to be immediately accretive to earnings, and the dividend policy isn't expected to change. All in, Medtronic is doing what it needs to do to get back on the growth path. And that should support continued dividend increases; the medical device maker only has two years to go before it hits Dividend King status (50+ years of annual dividend increases). June could be an opportune time to buy the stock hand over fist. Alexandria is a real estate investment trust (REIT), which seems pretty far away from healthcare. Its primary focus is on office properties, which also seems a bit removed from healthcare. The key here is that the REIT owns biomedical research facilities, which combine research space and office space in one property. Both are important to each other since the research takes place in specialized space, while the analysis of that research takes place in a normal office environment. Alexandria is one of the largest pure play medical research REITs you can buy. Alexandria counts some of the largest and most important medical research groups as tenants, from both the private side of the equation and the government side. However, like any landlord, the REIT's revenues will be impacted by the occupancy levels of its properties. And those rise and fall over time. Right now, occupancy is relatively weak, dropping to 91.7% at the end of the first quarter of 2025 from 94.6% at the end of 2024. Swings like this happen from time to time, but Wall Street is treating Alexandria as if its dividend is at a material risk of being cut. Only the funds from operations (FFO) payout ratio in the first quarter was a fairly strong 57%. There's room for adversity before a dividend cut would be in order. To be fair, office properties, and particularly highly specialized office properties, tend to have higher operating costs than other real estate assets. But it seems highly likely that Alexandria will manage its way through this weak patch and continue to extend its 15-year streak of annual dividend increases. For income lovers, this healthcare REIT is worth a deep dive in June. The average healthcare stock has an uninspiring dividend yield. But the average is made up of many different companies, some of which actually have very attractive dividend yields. That list includes industry-leading companies like Medtronic and Alexandria Real Estate. You might just want to pick up shares in one, or both, of these high yielders before June is over after you get to know them a little better. Before you buy stock in Medtronic, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Medtronic wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $664,089!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $881,731!* Now, it's worth noting Stock Advisor's total average return is 994% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Reuben Gregg Brewer has positions in Medtronic. The Motley Fool has positions in and recommends Alexandria Real Estate Equities. The Motley Fool recommends Medtronic and recommends the following options: long January 2026 $75 calls on Medtronic and short January 2026 $85 calls on Medtronic. The Motley Fool has a disclosure policy. 2 High-Yield Healthcare Dividend Stocks to Buy Hand Over Fist in June was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Should you name-drop on your LinkedIn headline?
Should you name-drop on your LinkedIn headline?

Fast Company

time3 hours ago

  • Fast Company

Should you name-drop on your LinkedIn headline?

What's the quickest way to get attention on LinkedIn? Some users think they've cracked the code by flaunting elite schools and prestigious firms at the very top of their profile where job titles typically go. Alums from the likes of consulting giant McKinsey, Harvard Business School, and investment bank Goldman Sachs are now shouting about their networks from the digital rooftops. But does name-dropping on your LinkedIn profile work? What about if you did a short stint at a company? Some people, like my husband, swear by this strategy, others think it's pretentious. Ultimately, it depends on who is looking. The benefits Leslie Danford, founder of Vitaminis, a vitamin juice shot brand sold nationally, says adding Bain, the consulting firm, and HBS to her LinkedIn headline has opened doors, especially since she had to fundraise for her company. 'Bain and HBS are standardized experiences—it's almost shorthand,' says Danford. Danford says that cluttering the top of her LinkedIn with something more detailed risks people skipping over her profile, whereas elite brand names can make a profile stand out. (LinkedIn caps headlines at 220 characters.) 'It's almost like a marketing headline,' she says. 'It's quick and delivers a message.' Unsurprisingly, the people who could benefit the most from this strategy are the ones who are not part of these elite networks to begin with, says Eric Lin, an associate professor at Oberlin College and Conservatory and chair of the business program. Lin has studied whether more detailed LinkedIn profiles boost pay. He found that people with more detailed LinkedIn profiles had higher pay and access to better opportunities, but this did not hold true for individuals with elite educational or work backgrounds. 'They have less to gain because they already have these networks,' he says. 'For those outside these circles, showcasing prestigious brands on a public platform like LinkedIn could help them reach people and opportunities they otherwise wouldn't.' The Drawbacks However, there can be downsides to name-dropping. For one, insiders may notice when someone is inflating their résumé such as listing a short course at HBS instead of a full MBA or an administrative role rather than client-facing work. 'If some people don't understand the differences, then the signal kind of works, for others it doesn't hold as much weight and maybe it backfires,' says Lin. In addition, Lin, who has researched scandal firms and halo firms, says perceptions can change at any moment. At one point, working for Enron, the energy giant, or Arthur Anderson, a top-tier accounting firm, was considered prestigious. In his research, Lin found that even when former employees mentioned those firms but had nothing to do with the period or position that caused the reputational fallout, they were more likely to take a hit on future pay just by association. Yet, it's not always clear how someone will feel about a company. Despite McKinsey's enormous brand value, some feel less warmly about the consulting firm due to its role in the opioid crisis. 'As things do or don't fall into favor, there's a loose association of stigma,' Lin says. (Lin has experience with both McKinsey and Harvard Business School, but does not name-drop them on this LinkedIn headline.) Many of those firms signal access to top-flight networks, not present-day experience, adds Megan Van Buiten, cofounder of People Conduit, a coaching firm. While it's likely the candidate had to endure a rigorous selection process to get into these elite companies, these brands don't tell recruiters much about an individual's skill set. 'It's kind of a networking magnet, but it can definitely raise red flags,' she adds. Some hiring managers may be suspicious about workers relying too heavily on gaining credibility from the elite institution versus showcasing skills like leadership or adaptability. Van Buiten recommends creating a LinkedIn headline that speaks to your current role and what impact you've had at your prior companies rather than tossing out names. Those interested in learning more about your experience can scroll your profile to find additional detail, she adds. 'It should not be used as a crutch,' she says. 'You want to convey more how you are as a person rather than a brand.' For instance, instead of saying ex-McKinsey, you might mention that you're a 'global strategy and transformation leader' or have built 'high performing teams,' she explains. John Peters, founder of shoe company Amberjack, recalls changing his LinkedIn headline roughly six years ago from listing his job as a management consultant to listing his elite affiliations. He needed to do cold reach outs on LinkedIn for his new company, which did not yet have a name, and he wanted to increase his chances of a reply. His LinkedIn now says: Founder | Ex-McKinsey | Cornell, which he feels is a testament to his credibility as an entrepreneur. Still, he admits to being on the fence about adding an Ivy League school and a top consulting firm to the headline. 'I really don't like that it feels braggadocio, but I felt inclined to do it,' says Peters. 'I'm trying to increase any chance of a reply.' Peters says he will never have empirical evidence of whether this is working, but since his current company does not have the name recognition, he's willing to risk it. Even when someone looks up his name outside of LinkedIn, they can see the elite education and work background without clicking on his profile. 'Every inch counts,' he says.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store